| Literature DB >> 25730773 |
Christian Hammer1, Podchanart Wanitchakool2, Lalida Sirianant2, Sergi Papiol1, Mathieu Monnheimer1, Diana Faria2, Jiraporn Ousingsawat2, Natalie Schramek3, Corinna Schmitt4, Gabriele Margos5, Angelika Michel6, Peter Kraiczy7, Michael Pawlita6, Rainer Schreiber2, Thomas F Schulz4, Volker Fingerle5, Hayrettin Tumani3, Hannelore Ehrenreich1,8, Karl Kunzelmann2.
Abstract
In a first genome-wide association study (GWAS) approach to anti-Borrelia seropositivity, we identified two significant single nucleotide polymorphisms (SNPs) (rs17850869, P = 4.17E-09; rs41289586, P = 7.18E-08). Both markers, located on chromosomes 16 and 3, respectively, are within or close to genes previously connected to spinocerebellar ataxia. The risk SNP rs41289586 represents a missense variant (R263H) of anoctamin 10 (ANO10), a member of a protein family encoding Cl(-) channels and phospholipid scramblases. ANO10 augments volume-regulated Cl(-) currents (IHypo) in Xenopus oocytes, HEK293 cells, lymphocytes and macrophages and controls volume regulation by enhancing regulatory volume decrease (RVD). ANO10 supports migration of macrophages and phagocytosis of spirochetes. The R263H variant is inhibitory on IHypo, RVD and intracellular Ca(2+) signals, which may delay spirochete clearance, thereby sensitizing adaptive immunity. Our data demonstrate for the first time that ANO10 has a central role in innate immune defense against Borrelia infection.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25730773 PMCID: PMC4461583 DOI: 10.2119/molmed.2014.00219
Source DB: PubMed Journal: Mol Med ISSN: 1076-1551 Impact factor: 6.354